Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 239

1.

Vaccine-elicited 10-kilodalton culture filtrate protein-specific CD8+ T cells are sufficient to mediate protection against Mycobacterium tuberculosis infection.

Wu Y, Woodworth JS, Shin DS, Morris S, Behar SM.

Infect Immun. 2008 May;76(5):2249-55. doi: 10.1128/IAI.00024-08. Epub 2008 Mar 10.

2.

Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens.

Brodin P, Majlessi L, Brosch R, Smith D, Bancroft G, Clark S, Williams A, Leclerc C, Cole ST.

J Infect Dis. 2004 Jul 1;190(1):115-22. Epub 2004 Jun 4.

PMID:
15195250
3.

Accelerated induction of mycobacterial antigen-specific CD8+ T cells in the Mycobacterium tuberculosis-infected lung by subcutaneous vaccination with Mycobacterium bovis bacille Calmette-Guérin.

Begum D, Umemura M, Yahagi A, Okamoto Y, Hamada S, Oshiro K, Matsuzaki G.

Immunology. 2009 Dec;128(4):556-63. doi: 10.1111/j.1365-2567.2009.03141.x.

4.

A novel DNA vaccine containing multiple TB-specific epitopes casted in a natural structure (ECANS) confers protective immunity against pulmonary mycobacterial challenge.

Gao H, Yue Y, Hu L, Xu W, Xiong S.

Vaccine. 2009 Aug 27;27(39):5313-9. doi: 10.1016/j.vaccine.2009.06.093. Epub 2009 Jul 16.

PMID:
19615961
5.

Protection conferred by heterologous vaccination against tuberculosis is dependent on the ratio of CD4(+) /CD4(+)  Foxp3(+) cells.

Fedatto PF, Sérgio CA, Paula MO, Gembre AF, Franco LH, Wowk PF, Ramos SG, Horn C, Marchal G, Turato WM, Silva CL, da Fonseca DM, Bonato VL.

Immunology. 2012 Nov;137(3):239-48. doi: 10.1111/imm.12006.

6.

Mycobacterium tuberculosis culture filtrate proteins plus CpG Oligodeoxynucleotides confer protection to Mycobacterium bovis BCG-primed mice by inhibiting interleukin-4 secretion.

da Fonseca DM, Silva CL, Wowk PF, Paula MO, Ramos SG, Horn C, Marchal G, Bonato VL.

Infect Immun. 2009 Dec;77(12):5311-21. doi: 10.1128/IAI.00580-09. Epub 2009 Sep 14.

8.

Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.

Changhong S, Hai Z, Limei W, Jiaze A, Li X, Tingfen Z, Zhikai X, Yong Z.

Tuberculosis (Edinb). 2009 Jan;89(1):54-61. doi: 10.1016/j.tube.2008.09.005. Epub 2008 Dec 3.

PMID:
19056317
9.

Effects of DNA- and Mycobacterium bovis BCG-based delivery of the Flt3 ligand on protective immunity to Mycobacterium tuberculosis.

Triccas JA, Shklovskaya E, Spratt J, Ryan AA, Palendira U, Fazekas de St Groth B, Britton WJ.

Infect Immun. 2007 Nov;75(11):5368-75. Epub 2007 Aug 27.

10.

Vaccination with the T cell antigen Mtb 8.4 protects against challenge with Mycobacterium tuberculosis.

Coler RN, Campos-Neto A, Ovendale P, Day FH, Fling SP, Zhu L, Serbina N, Flynn JL, Reed SG, Alderson MR.

J Immunol. 2001 May 15;166(10):6227-35.

11.
12.
13.

Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon.

Radosevic K, Wieland CW, Rodriguez A, Weverling GJ, Mintardjo R, Gillissen G, Vogels R, Skeiky YA, Hone DM, Sadoff JC, van der Poll T, Havenga M, Goudsmit J.

Infect Immun. 2007 Aug;75(8):4105-15. Epub 2007 May 25.

14.

Aerosol vaccination with AERAS-402 elicits robust cellular immune responses in the lungs of rhesus macaques but fails to protect against high-dose Mycobacterium tuberculosis challenge.

Darrah PA, Bolton DL, Lackner AA, Kaushal D, Aye PP, Mehra S, Blanchard JL, Didier PJ, Roy CJ, Rao SS, Hokey DA, Scanga CA, Sizemore DR, Sadoff JC, Roederer M, Seder RA.

J Immunol. 2014 Aug 15;193(4):1799-811. doi: 10.4049/jimmunol.1400676. Epub 2014 Jul 14.

15.
17.

A novel DNA vaccine containing multiple TB-specific epitopes cast in a natural structure elicits enhanced Th1 immunity compared with BCG.

Gao H, Li K, Yu S, Xiong S.

Microbiol Immunol. 2009 Oct;53(10):541-9. doi: 10.1111/j.1348-0421.2009.00157.x.

18.

Improved cellular immune response elicited by a ubiquitin-fused ESAT-6 DNA vaccine against Mycobacterium tuberculosis.

Wang QM, Kang L, Wang XH.

Microbiol Immunol. 2009 Jul;53(7):384-90. doi: 10.1111/j.1348-0421.2009.00138.x.

20.

A DNA vaccine expressing CFP21 and MPT64 fusion protein enhances BCG-induced protective immunity against Mycobacterium tuberculosis infection in mice.

Wang C, Chen Z, Fu R, Zhang Y, Chen L, Huang L, Li J, Shi C, Fan X.

Med Microbiol Immunol. 2011 Aug;200(3):165-75. doi: 10.1007/s00430-011-0188-z. Epub 2011 Feb 22.

PMID:
21340709

Supplemental Content

Support Center